Sound Bioventures: Putting Scandinavian Biotechs on the Global Stage

Johan Kördel Ph.D., Managing Partner - Sound Bioventures

In this keynote presentation from the BioStock Global Forum, Sound Bioventures’ Managing Partner Johan Kordel discusses the importance of Scandinavian biotch companies taking a strong international presence.

Johan dives into the specific challenges and opportunities facing Nordic life science companies, offering valuable insights from a venture investor’s perspective. He explores strategies for making these companies more attractive on the global stage and achieving success within the international biotech industry.

Sound Bioventures: Your Partner in Global Reach

As a company with a strong transatlantic presence and extensive local and global networks, Sound Bioventures is uniquely positioned to support Nordic private companies as they navigate the clinical and post-clinical stages.

Listen to his presentation to learn how Sound Bioventures can help your company achieve its global ambitions:

NephroDI Therapeutics Announces Investment by Sound Bioventures to Accelerate Development of NDI-5001 as a Potential First-in-Class Therapy for Pediatric Orphan Kidney Disease

June 20, 2024 Seattle, WA – NephroDI Therapeutics (NephroDI), a near-clinical stage pharmaceutical company focusing on kidney disorders, announces a Series A investment from life sciences VC Sound Bioventures. together with a previously announced strategic corporate partnership, the capital will be used to advance NDI-5001, a proprietary small mole ...


* indicates required